Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants

被引:20
作者
Esposito, S
Faldella, G
Giammanco, A
Bosis, S
Friscia, O
Clerici, M
Principi, N
机构
[1] Univ Milan, Dept Pediat 1, I-20122 Milan, Italy
[2] Univ Milan, Chair Immunol, I-20157 Milan, Italy
[3] GlaxoSmithKline SpA, I-37135 Verona, Italy
[4] Univ Palermo, Dept Hyg & Microbiol, I-90134 Palermo, Italy
[5] Univ Bologna, Inst Pediat & Neonatol, I-40138 Bologna, Italy
关键词
pre-term infants; pertussis; DTaP-HBV vaccine;
D O I
10.1016/S0264-410X(02)00230-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Immunoglobulin G (IgG) antibody titres against pertussis antigens, Bordetella pertussis-specific proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) were evaluated at the age of 5-6 years in 13 children who had been pre-term infants with a gestational age (GA) of less than or equal to31 weeks, 10 who had been pre-term infants with a GA of 32-37 weeks, and 15 who had been term infants with a GA of 38-42 weeks. All of the infants had been immunised with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine (DTaP-HBV) at 3, 5, and 11 months of post-natal age. Our results show that the long-term immune responses induced by primary pertussis vaccination in the pre-term infants (especially those with a GA of less than or equal to31 weeks) were qualitatively and quantitatively lower than those observed in the term infants. In order to maintain an adequate pertussis-specific immune response, in term children a booster at 5-6 years of age may be suggested, whereas in pre-term an earlier booster should be useful. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2928 / 2932
页数:5
相关论文
共 16 条
[1]
Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine [J].
Ausiello, CM ;
Lande, R ;
Urbani, F ;
Di Carlo, B ;
Stefanelli, P ;
Salmaso, S ;
Mastrantonio, P ;
Cassone, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :1989-1995
[2]
Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines [J].
Ausiello, CM ;
Urbani, F ;
laSala, A ;
Lande, R ;
Cassone, A .
INFECTION AND IMMUNITY, 1997, 65 (06) :2168-2174
[3]
Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines [J].
Cassone, A ;
Ausiello, CM ;
Urbani, F ;
Lande, R ;
Giuliano, M ;
LaSala, A ;
Piscitelli, A ;
Salmaso, S .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1997, 151 (03) :283-289
[4]
Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection [J].
Esposito, S ;
Agliardi, T ;
Giammanco, A ;
Faldella, G ;
Cascio, A ;
Bosis, S ;
Friscia, O ;
Clerici, M ;
Principi, N .
INFECTION AND IMMUNITY, 2001, 69 (07) :4516-4520
[5]
Clinical development of a combined diphtheria, tetanus, acellular pertussis, and hepatitis B vaccine in Italy [J].
Faldella, G ;
Alessandroni, R ;
Fantini, MP ;
Salvioli, GP .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S298-S301
[6]
The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine [J].
Faldella, G ;
Alessandroni, R ;
Magini, GM ;
Perrone, A ;
Sabatini, MR ;
Vancini, A ;
Salvioli, GP .
VACCINE, 1998, 16 (17) :1646-1649
[7]
Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis [J].
Giuliano, M ;
Mastrantonio, P ;
Giammanco, A ;
Piscitelli, A ;
Salmaso, S ;
Wassilak, SGF .
JOURNAL OF PEDIATRICS, 1998, 132 (06) :983-988
[8]
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis [J].
Greco, D ;
Salmaso, S ;
Mastrantonio, P ;
Giuliano, M ;
Tozzi, AE ;
Anemona, A ;
Atti, MLCD ;
Giammanco, A ;
Panei, P ;
Blackwelder, WC ;
Klein, DL ;
Wassilak, SGF ;
Stefanelli, P ;
Bottone, M ;
Sofia, T ;
Luzi, S ;
Bellomi, G ;
Cobianchi, F ;
Canganella, G ;
Meduri, F ;
Scuderi, G ;
Chiarini, A ;
Maggio, M ;
Taormina, S ;
Genovese, M ;
Moiraghi, A ;
Barale, A ;
DiTommaso, S ;
Malaspina, S ;
Vasile, E ;
Ferraro, P ;
DalLago, P ;
DeMarzi, L ;
Robino, L ;
Giraldo, E ;
Coppola, N ;
Materassi, P ;
Castellani, GT ;
Basso, F ;
Barbuti, S ;
Quarto, M ;
Lopalco, P ;
DOrazio, P ;
Sanguedolce, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :341-348
[9]
HE H, 1998, INFECT IMMUN, V66, P3797
[10]
OUTCOMES OF BORDETELLA-PERTUSSIS INFECTION IN DIFFERENT AGE-GROUPS OF AN IMMUNIZED POPULATION [J].
HE, QS ;
VILJANEN, MK ;
NIKKARI, S ;
LYYTIKAINEN, R ;
MERTSOLA, J .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (04) :873-877